Table 1.
Patient demographics and characteristics at baseline in 93 patients with LNSC measurements available at baseline
| Demographic variable | Pasireotide 600 µg bid (n = 48) | Pasireotide 900 µg bid (n = 45) |
|---|---|---|
| Median age (years) | 38.0 | 37.0 |
| Male:female (n) | 13:35 | 9:36 |
| Race [n (%)] | ||
| Caucasian | 34 (70.8) | 30 (66.7) |
| Black | 0 (0) | 1 (2.2) |
| Asian | 10 (20.8) | 10 (22.2) |
| Other | 4 (8.4) | 4 (8.8) |
| Median time since diagnosis (months) | 20.2 | 38.8 |
| Previous surgery [n (%)] | 35 (72.9) | 37 (82.2) |
| Median LNSC level (nmol/L) | 17.3 | 10.3 |